Part Three: Guidelines and Treatment Approaches

Contents:

• Fourth ACCP Consensus Conference on Antithrombotic Therapy
• ACCP Recommendations, 1995
• ACCP Recommendations for Stroke Prevention in Atrial Fibrillation
• PORT Study Findings
• Optimal Intensity for Warfarin Therapy
• Risk of Intracranial Hemorrhage in Outpatients
• Recommended Range for Warfarin Therapy
• Relationship Between PT Ratio and INR
• Guidelines for Initiating Warfarin Therapy
• Atrial Fibrillation and Cardioversion
• Reimbursement for Monitoring
• Medical Benefits of Anticoagulation Clinics
• Financial Benefits of Anticoagulation Therapy
• Legal Benefit of Meeting Standard of Care
• Threat of Strokes
• Case Studies
• Sample Dosing Protocol
• Issues for Stroke prevention in AF Patients
• Why Change AF Care Strategy?
• Issues for Stroke Prevention in AF Patients
• Clinical Pathway for Management of Atrial Fibrillation
• Stroke Prevention in Atrial Fibrillation

 

Part One: Pathophysiology and Clinical Manifestations

Part Two: Major Clinical Trials